Delivery Order SPE2DB20D3103-SPE2DB24FM6D5
Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,500.00 firm fixed-price delivery order is for the supply of Doxorubicin Liposome 50mg/25ml, a specialty medication. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,700.00 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564312466 - Doxorubicin Liposome 20mg/10ml 10ml, with a period of performance through April 18, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
- This federal contract award is a delivery order (SPE2DB20D3103|SPE2DB24FM4V2) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563493004 - Doxorubicin Liposome 50mg/25ml 25ml. The $1,500.00 firm fixed price award was made by the Defense Logistics Agency (DLA) on January 30, 2024, with a completion date of January 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Doxorubicin Liposome 50mg/25ml in 25ml units, with a ceiling value of $1,796.98. The contract is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded without set-aside designation. This delivery order is...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 50 mg/25 mL vials of the chemotherapy drug doxorubicin liposome, with a ceiling value of $2,647.26 and a completion date of July 14, 2025. This is a firm fixed-price, non-set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $1,691.20 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564010703 ! DOXIL 20 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as Amerisourcebergen's primary contract vehicle to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,633.80 firm fixed-price delivery order is for the supply of Doxil 50 mg/25 ml vials, with a completion date of December 30, 2021. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the U.S. Department of...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $1,260.58 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract was awarded without a set-aside designation and has an ultimate completion date of June 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, will provide a variety of pharmaceutical products and medical supplies to support the DLA's mission of providing logistics, acquisition, and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price Delivery Order contract worth $1,182.71 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is for the supply of pharmaceutical products, including a 0.25% 10ML medication, to support military treatment programs and facilities. The contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Doxil 50 mg/25 ml vials. The order has a potential value of $3,051.42 and a completion date of December 28, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and distribution...